Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
Pfizer is an American, multinational pharmaceutical and biotechnology corporation. | ||||||
Novartis is a healthcare and pharmaceutical company based in Basel, Switzerland, incorporated in 1996. | ||||||
AstraZeneca is a global biopharmaceutical business founded in 1999. | ||||||
Novo Nordisk is a danish company founded in 1923 by David Thompson, August Krogh and Hans Christian Hagedorn. | ||||||
Caribou Biosciences is a Berkeley, California—based private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz. | ||||||
Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing. | ||||||
A biotechnology company using placental mesenchymal stem cells to develop cell therapies for medical conditions such as inflammation, ischemia, hematological disorders, and radiation. | ||||||
Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease. | ||||||
Rubius Therapeutics is a biotechnology company using stem cells to develop red blood cell cellular therapies. | ||||||
A clinical-stage biopharmaceutical company engaging in drug discovery and drug development for treating autoimmune disease and cancer. | ||||||
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology. | ||||||
Allogene Therapeutics is a San Francisco, California-based biotechnology company specializing in the development of allogeneic CAR T("AlloCAR TTM") therapies for cancer. | ||||||
A regenerative medicine company developing biologic products for inflammatory ailments, cardiovascular disease and back pain | ||||||
A pharmaceutical company developing treatments for cancer and chronic diseases. It was founded in 2006 and is located in San Diego, California. | ||||||
Senti Biosciences is a synthetic biology company. | ||||||
eGenesis is a Cambridge, MA - based startup that uses gene editing tech for xenotransplantation procedures in the medical industry. | ||||||
A biopharmaceutical and gene editing company founded in 2013. CRISPR Therapeutics AG is based in Zug, Switzerland and CRISPR Therapeutics, Inc. is the U.S. subsidiary with R&D operations in Cambridge, Massachusetts and business offices in London, U.K. | ||||||
Cellular Biomedicine Group is a biotechnology company developing cell therapies for degenerative and cancerous diseases. | ||||||
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited. | ||||||
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity. | ||||||
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles. | ||||||
IMV is a Canadian biopharmaceutical company focused on developing immunotherapies for serious human diseases using its proprietary lipid-based delivery system, which the company calls DPX. | ||||||
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products. | ||||||
Vaccitech is a T cell immunotherapy company developing products to treat and prevent infectious disease and cancer | ||||||
A biotechnology that specializes in genome editing, gene therapy, cell therapy and gene regulation. |